Comparative analysis of the diagnostic significance of heart failure markers in comorbid patients with atrial fibrillation and chronic obstructive pulmonary disease

QR Code

Comparative analysis of the diagnostic significance of heart failure markers in comorbid patients with atrial fibrillation and chronic obstructive pulmonary disease

Objective: to assess the diagnostic significance of atrial and brain natriuretic peptides for the detection of chronic heart failure in comorbid patients with atrial fibrillation and chronic obstructive pulmonary disease. Materials and methods: 120 patients depending on the presence of chronic obstr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tatiana A. Dzyurich, Anna I. Chesnikova, Vladimir P. Terentyev, Olga E. Kolomatskaya
Format:	Article
Language:	English
Published:	State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2019-04-01
Series:	Медицинский вестник Юга России
Subjects:	chronic heart failure natriuretic peptides atrial fi brillation chronic obstructive pulmonary disease comorbid patients
Online Access:	https://www.medicalherald.ru/jour/article/view/868
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Features and the NT-proBNP Marker in Patients with Chronic Heart Failure in the Setting of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
by: Т. A. Dzyurich, et al.
Published: (2019-09-01)

Calculation of the cut-off and evaluation of the dynamics of natriuretic peptide for optimization the management of comorbid patients with thyrototoxicosis and heart failure
by: E. V. Pashchenko, et al.
Published: (2018-12-01)

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

Amiodarone-Induced Hypothyroidism
by: Svetlana A. Chepurnenko, et al.
Published: (2019-12-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

The impact of chronic obstructive pulmonary disease and hypertension on the development and progression of atrial fibrillation
by: L. D. Khidirova, et al.
Published: (2019-11-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2017-01-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2016-03-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

Relationship between right atrial dilation and paroxysmal atrial fibrillation in patients with hypertension and chronic obstructive pulmonary disease
by: A. I. Tarzimanova, et al.
Published: (2025-03-01)

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
by: E V Schlyakhto, et al.
Published: (2022-01-01)

Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness”
by: S. V. Malchikova, et al.
Published: (2019-10-01)

Chronic obstructive pulmonary disease is associated with higher recurrence rates of atrial fibrillation following catheter ablation
by: Ree Lu, et al.
Published: (2025-05-01)

Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics
by: R. E. Tokmachev, et al.
Published: (2018-12-01)

Systemic inflammation and complications of”vascular" comorbidity in patients with COPD
by: A. S. Skotnikov, et al.
Published: (2015-10-01)

Efficiency of meldonium application in complex treatment of patients with chronic heart failure decompensation
by: A. S. Sycheva, et al.
Published: (2021-06-01)

An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants?
by: T. V. Pavlova
Published: (2020-12-01)

CENTRAL HEMODYNAMIC PARAMETERS IN PATIENTS WITH IDIOPATHIC ATRIAL FIBRILLATION
by: K. V. trakhova, et al.
Published: (2011-06-01)

Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban
by: O. L. Barbarash, et al.
Published: (2020-11-01)

Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation
by: T. V. Pavlova
Published: (2022-01-01)

A patient with atrial fibrillation and comorbidities in clinical practice
by: A. S. Skotnikov, et al.
Published: (2020-12-01)

The role of cardiac biomarkers and epicardial fat in the diagnosis of heart failure in patients with various types of atrial fibrillation
by: D. V. Losik, et al.
Published: (2022-05-01)

COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD
by: Chen Q, et al.
Published: (2025-06-01)

INFLUENCE OF SOMATIC COMORBIDITY ON THE COURSE OF CORONARY HEART DISEASE
by: E. B. Akhmedova, et al.
Published: (2017-10-01)

Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders
by: L. D. Khidirova, et al.
Published: (2019-07-01)

Comparative characteristics of patients with a combination of obstructive sleep apnea and paroxysmal atrial fibrillation in the groups of interventional and conservative treatment of arrhythmia
by: N. T. Obukhova, et al.
Published: (2024-08-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Psychiatric comorbidities and smoking behavior in chronic obstructive pulmonary disease: A case–control study from a north Indian tertiary Center
by: Rohit Pathak, et al.
Published: (2025-08-01)

FEATURES OF THE COURSE AND PROGRESSION OF ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND NONCARDIAC PATHOLOGY
by: L. D. Khidirova, et al.
Published: (2019-05-01)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015-09-01)

The combination of atrial fibrillation and obstructive sleep apnea — is there a connection?
by: G. G. Arutyunyan, et al.
Published: (2018-12-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Clinical and biochemical phenotypes in cardiorespiratory comorbidity
by: T. V. Prokofyeva, et al.
Published: (2023-07-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function
by: N. V. Drobotya, et al.
Published: (2020-05-01)

FEATURES OF ARTERIAL HYPERTENSION IN PATIENTS WITH COMORBIDITY
by: A. I. Chesnikova, et al.
Published: (2017-03-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

Effect of CPAP therapy on left atrial remodeling in patients with paroxysmal atrial fibrillation and obstructive sleep apnea undergoing pulmonary vein isolation
by: A. G. Topchyan, et al.
Published: (2022-08-01)

Proinflammatory cytokines in patients with acute myocardial infarction against the background of chronic obstructive pulmonary disease
by: A. V. Naumov, et al.
Published: (2020-09-01)